Cancer Antigen 125 (Mucin 1) Serum/Plasma Concentration
This test measures the level of a protein called CA 125, which may be produced by certain types of cancer, including ovarian cancer. It can help monitor treatment progress or detect recurrence.
CA 125 levels may rise in some cancers but also in non-cancerous conditions; results should be interpreted by a healthcare provider in context.
Key facts at a glance
- LOINC
- 13127-6
- Short code
- CA70K
- Synonyms
- Cancer Ag DM/70K SerPl-aCnc
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top tube; plasma may be collected in heparin or EDTA tubes.
- Units
- N/A
- Ref low
- 0
- Ref high
- 5
- Critical range
- 0.5 N/A – —
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunoassay (e.g., ELISA, Chemiluminescent Immunoassay)
- CPT
- 86316
- SNOMED
- 115341005
- Specimen volume
- 1-2 mL of serum or plasma
- Stability
- Stable for 24 hours at 2-8°C; for longer storage, freeze at -20°C or below for up to 6 months. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
What Is CA 125 Used For?
CA 125 is primarily used as a biomarker for ovarian cancer screening, diagnosis, and monitoring. It may also help track response to treatment or identify recurrence. However, it is not a definitive test for cancer alone—results should be reviewed alongside clinical findings and imaging.
How Is This Test Performed?
A blood sample is drawn from a vein in your arm. The blood is then processed to separate serum or plasma, which is tested for CA 125 levels using an immunoassay method. Results are reported in arbitrary units per milliliter (U/mL).
What Does a High or Low Level Mean?
Elevated CA 125 levels may suggest ovarian cancer or other conditions like endometriosis, pelvic inflammation, or liver disease. However, many non-cancerous conditions can also cause elevated levels. Low levels are less commonly associated with cancer but may indicate normal health or other factors.
When Might You Need This Test?
Your doctor may order a CA 125 test if you have symptoms like abdominal pain, bloating, or irregular periods. It may also be used during cancer screening, follow-up care, or before surgery for ovarian cancer.
Reference range
Generally <5 U/mL (varies by laboratory and assay manufacturer); values vary depending on the specific CA 70K assay used.N/A
No fasting required. Inform the clinician of any recent diagnostic procedures (e.g., imaging with contrast) or medications that may affect results.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance: CA 125 is a tumor marker that can indicate ovarian cancer risk but is not specific enough alone to diagnose it. It is often used alongside other tests (like ultrasounds or CA 19-9) and clinical assessments. False positives or negatives can occur, so results should be discussed with your healthcare provider.
Short name
CA 125 (Mucin 1)
Frequently asked questions
Why might my CA 125 test be ordered if I don’t have cancer symptoms?
Can CA 125 levels change without cancer?
How often should I get this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy